Literature DB >> 30014506

Multicrossover Randomized Controlled Trial Designs in Alzheimer Disease.

Steven E Arnold1, Rebecca A Betensky2.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 30014506      PMCID： PMC6481185          DOI： 10.1002/ana.25280

Source DB:  PubMed          Journal:  Ann Neurol        ISSN： 0364-5134            Impact factor:   10.422


× No keyword cloud information.
  58 in total

1.  The self-controlled and self-recorded clinical trial for low-grade morbidity.

Authors:  L HOGBEN; M SIM
Journal:  Br J Prev Soc Med       Date:  1953-10

2.  An inventory to assess activities of daily living for clinical trials in Alzheimer's disease. The Alzheimer's Disease Cooperative Study.

Authors:  D Galasko; D Bennett; M Sano; C Ernesto; R Thomas; M Grundman; S Ferris
Journal:  Alzheimer Dis Assoc Disord       Date:  1997       Impact factor: 2.703

3.  The history and development of N-of-1 trials.

Authors:  R D Mirza; S Punja; S Vohra; G Guyatt
Journal:  J R Soc Med       Date:  2017-08       Impact factor: 5.344

4.  Combining single patient (N-of-1) trials to estimate population treatment effects and to evaluate individual patient responses to treatment.

Authors:  D R Zucker; C H Schmid; M W McIntosh; R B D'Agostino; H P Selker; J Lau
Journal:  J Clin Epidemiol       Date:  1997-04       Impact factor: 6.437

Review 5.  An Overview of New Possible Treatments of Alzheimer's Disease, Based on Natural Products and Semi-Synthetic Compounds.

Authors:  Enrico Zanforlin; Giuseppe Zagotto; Giovanni Ribaudo
Journal:  Curr Med Chem       Date:  2017-11-17       Impact factor: 4.530

6.  Measurement of functional activities in older adults in the community.

Authors:  R I Pfeffer; T T Kurosaki; C H Harrah; J M Chance; S Filos
Journal:  J Gerontol       Date:  1982-05

7.  Change in cognitive function in older persons from a community population: relation to age and Alzheimer disease.

Authors:  R S Wilson; L A Beckett; D A Bennett; M S Albert; D A Evans
Journal:  Arch Neurol       Date:  1999-10

8.  Agitated behaviors in the elderly. II. Preliminary results in the cognitively deteriorated.

Authors:  J Cohen-Mansfield
Journal:  J Am Geriatr Soc       Date:  1986-10       Impact factor: 5.562

9.  Consistency and inconsistency in network meta-analysis: model estimation using multivariate meta-regression.

Authors:  Ian R White; Jessica K Barrett; Dan Jackson; Julian P T Higgins
Journal:  Res Synth Methods       Date:  2012-06       Impact factor: 5.273

Review 10.  Pathophysiologic relationship between Alzheimer's disease, cerebrovascular disease, and cardiovascular risk: A review and synthesis.

Authors:  Cláudia Y Santos; Peter J Snyder; Wen-Chih Wu; Mia Zhang; Ana Echeverria; Jessica Alber
Journal:  Alzheimers Dement (Amst)       Date:  2017-02-09
View more
  4 in total

1.  Reappraising the variability of effects of antipsychotic medication in schizophrenia: a meta-analysis.

Authors:  Robert A McCutcheon; Toby Pillinger; Orestis Efthimiou; Marta Maslej; Benoit H Mulsant; Allan H Young; Andrea Cipriani; Oliver D Howes
Journal:  World Psychiatry       Date:  2022-06       Impact factor: 79.683

2.  A pilot protocol to assess the feasibility of a virtual multiple crossover, randomized controlled trial design using methylphenidate in mild cognitive impairment.

Authors:  Libby A DesRuisseaux; Victoria J Williams; Alison J McManus; Anoopum S Gupta; Becky C Carlyle; Hamed Azami; Jessica A Gerber; Anna M Bolling; Carolyn L Cook; Rebecca A Betensky; Steven E Arnold
Journal:  Trials       Date:  2020-12-11       Impact factor: 2.279

3.  Long-term digital device-enabled monitoring of functional status: Implications for management of persons with Alzheimer's disease.

Authors:  Natalie A Manley; Eléonore Bayen; Tamara L Braley; Jennifer Merrilees; Amy M Clark; Bradley Zylstra; Michael Schaffer; Alexandre M Bayen; Katherine L Possin; Bruce L Miller; A Katrin Schenk; Stephen J Bonasera
Journal:  Alzheimers Dement (N Y)       Date:  2020-06-14

4.  Individual Postprandial Glycemic Responses to Diet in n-of-1 Trials: Westlake N-of-1 Trials for Macronutrient Intake (WE-MACNUTR).

Authors:  Yue Ma; Yuanqing Fu; Yunyi Tian; Wanglong Gou; Zelei Miao; Min Yang; José M Ordovás; Ju-Sheng Zheng
Journal:  J Nutr       Date:  2021-10-01       Impact factor: 4.798
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.